
Article content material
SARNIA, Ontario, Dec. 01, 2022 (GLOBE NEWSWIRE) — Breast Most cancers Canada at this time introduced a name for proposals for his or her 2023 Precision Oncology Analysis Grants which is able to award $500,000 in new funding for breast most cancers analysis initiatives. The submission interval begins at this time, December 1, and can stay open till December 23, 2022.
Commercial 2
Article content material
Because of the beneficiant help of Breast Most cancers Canada donors by means of 2022, the group has elevated their new grants funding for the yr forward by $150,000 for his or her second annual name for proposals. The group granted $350,000 in new funding to precision oncology initiatives throughout Canada in 2022, a lot of that are persevering with into the brand new yr.
Article content material
“With a number of Canadian organizations having to scale back funding for breast most cancers analysis, we’re proud to proceed elevating precision oncology analysis initiatives that can have direct affect on sufferers,” stated Shaniah Leduc, Chair of Breast Most cancers Canada. “We all know due to analysis there are greater than 50 sorts of breast most cancers. Precision oncology analysis permits us to extra precisely diagnose breast most cancers and design therapy plans focused to the affected person’s particular kind of breast most cancers. The objective is to match the fitting therapy, to the fitting particular person, on the proper time.”
Commercial 3
Article content material
Breast Most cancers Canada’s Scientific Advisory Committee is main the choice course of and is dedicated to listening to breast most cancers sufferers. All funded venture groups are required to incorporate a breast most cancers affected person advocate or a neighborhood breast most cancers advocacy group as a part of their analysis.
The chosen initiatives will deal with precision oncology that ship individualized therapy fashions and speed up the transition from commonplace approaches for breast most cancers therapy, to the brand new age of customized drugs. The initiatives will encompass 4 divisions of precision oncology analysis: primary science, screening and detection, customized therapy, and affected person reported outcomes. All initiatives should additionally embody a synthetic intelligence (AI) part.
Commercial 4
Article content material
“We’re extremely grateful to our donors, companions and volunteers for the unwavering help all through 2022. As our donations enhance, so does the variety of initiatives we are able to fund. Collectively, we’re saving lives by means of breast most cancers analysis” stated Kimberly Carson, CEO, Breast Most cancers Canada.”
Canadian scientists and researchers are invited to submit an software for precision oncology breast most cancers analysis initiatives by December 23, 2022. For extra info and to use, please go to breastcancerprogress.ca.
Breast Most cancers Canada
Breast Most cancers Canada (BCC) is a nationwide, registered charity devoted to saving lives by means of breast most cancers analysis. BCC raises cash to fund patient-focused analysis for the analysis and therapy of breast most cancers. For extra info, please go to breastcancerprogress.ca.
MEDIA CONTACTS
Victoria Mahoney, Concord Advertising and marketing
416-464-7606
[email protected]
Angela Marlatt, Breast Most cancers Canada
800-567-8767 ext. 707
[email protected]
A photograph accompanying this announcement is out there at https://www.globenewswire.com/NewsRoom/AttachmentNg/20b46eaa-215a-49d3-b3ad-46206b4dc889